+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

T Cell Lymphoma - Epidemiology Forecast - 2032 - Product Thumbnail Image

T Cell Lymphoma - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Zollinger Ellison Syndrome - Epidemiology Forecast - 2032 - Product Thumbnail Image

Zollinger Ellison Syndrome - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HER2 Lung Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

HER2 Lung Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Gastrointestinal Cancer - Epidemiology Forecast - 2032 - Product Thumbnail Image

Gastrointestinal Cancer - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Wilms Tumor - Epidemiology Forecast to 2032 - Product Thumbnail Image

Wilms Tumor - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Urothelial Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Urothelial Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Leptomeningeal Metastases - Epidemiology Forecast - 2032 - Product Thumbnail Image

Leptomeningeal Metastases - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Rhabdomyosarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Rhabdomyosarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hairy Cell Leukemia (HCL) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hairy Cell Leukemia (HCL) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hepatocellular Carcinoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hepatocellular Carcinoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
HER2-Negative Breast Cancer - Epidemiology Forecast to 2032 - Product Thumbnail Image

HER2-Negative Breast Cancer - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Leiomyosarcoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Leiomyosarcoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Mantle Cell Lymphoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Mantle Cell Lymphoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Melanoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Melanoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Waldenstrom Macroglobulinemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Glioblastoma Multiforme (GBM) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

ATEZOLIZUMAB - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 50 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more